Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
Submitted by
admin
on June 13, 2016 - 7:10pm
Source:
Fierce Pharma
News Tags:
JNJ
Invokana
type 1 diabetes
Janssen
Headline:
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
Do Not Allow Advertisers to Use My Personal information
